Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-07-01-Speech-2-149"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-07-01"^^xsd:date2
dcterms:Is Part Of	lp_eu:Strengthening the European pharmaceutical industry in the interest of patients – proposals for action2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20030701.6.2-149"2
lpv:hasSubsequent	lp_eu:2003-07-01-Speech-2-1502
lpv:speaker	lp:Armonia Bordes2
lpv:spokenAs	member; EUL/NGL (1999-07-20--2004-07-19)3 substitute; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 member; ECON (2002-01-17--2004-07-19)3 member; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees and Delegation for relations with Tadjikistan, Turkmenistan and Mongolia (2002-02-07--2004-07-19)3 member; Committee on Women's Rights and Equal Opportunities (2002-01-17--2004-07-19)3 unknown; Lutte ouvrière (1999-07-20--2004-07-19)3
lpv:translated text	"Mr President, having worked for over thirty years for one of the major international pharmaceutical companies, I can tell you that the main concern of this industry, whether European or otherwise, is neither people’s health – and especially not the health of people who cannot afford to pay for their medicines – nor the well-being of its employees, whom it does not hesitate to make redundant by the thousand whenever a merger or concentration takes place in the sector or to drive hard, day and night, even the women, in manufacturing and packing medicines. These practices are all the more scandalous because the pharmaceuticals industry is one of the most profitable of all. The sole concern of this industry is the financial well-being of its shareholders. Before bringing out a new medicine, the major companies first undertake marketing studies, which determine whether research in the field is continued or stopped. This means that companies are only interested in illnesses that generate money. Too bad if a growing number of men and women find it harder and harder to look after themselves; too bad if in Africa and elsewhere, children are still dying in this day and age of easily curable diseases such as measles, and too bad for those people suffering from malaria or other diseases that affect the populations of poor countries. The only decision that could satisfy both the employees of these companies and patients – in rich countries and in the developing world – would be for this industry no longer to be a private industry in which only the interests of a minority count, and for it to be placed under the control of the people, for the benefit of everyone."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph